Owing to the nature of CIP2A/p90, which can play important roles in the proliferation, apoptosis, invasion, migration, EMT, cell cycle, and drug resistance of tumor cells, it can be used as a potential diagnostic biomarker, as well as an antitumor drug target. The gene discussed is CIP2A; the disease is neoplasm.